Literature DB >> 8748664

Behavioural effects of adenosine locally applied into ventral hippocampus of adult male rats.

S L Salas1, F A Redmond, E O Alvarez.   

Abstract

The possible effects of Adenosine (AD), locally applied into the ventral Hippocampus (HPCv) on the expression of general motor activity and some stereotyped behaviours were studied in adult male rats. Locomotion display was recorded in a hole-board equipped with automatic infrared animal activity detectors. Stereotyped behaviours were measured by direct inspection by two observers. Animals were implanted with microinjection cannulae into the HPCv and 72 h later they were injected with saline, or increasing doses of AD. In one experiment rats were microinjected once with saline or Adenosine and general motor activity and exploration were examined. In other experiment, rats were injected into the HPCv twice with saline, the AD-receptors antagonist 1,3-dipropil-methyl-xanthine (DMX) or AD and only stereotyped behaviours were examined. Results of Experiment 1 showed that the 40 nMol dose of AD was significantly effective to inhibit by about 30% several motor activities such as vertical, horizontal and ambulatory behaviours. Results of Experiment 2, showed that grooming was not modified by AD but the dose of 10 nMol increased the time of immobility by about 3 times over controls. DMX was able to block completely the AD effects on immobility. The present results suggest that in the rat AD might modulate the hippocampal-mediated expression of some motor and stereotyped behaviours induced by unknown environments.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8748664     DOI: 10.1007/bf01276866

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  35 in total

1.  Chronic theophylline treatment increases adenosine A1, but not A2, receptor binding in the rat brain: an autoradiographic study.

Authors:  C R Lupica; R F Berman; M F Jarvis
Journal:  Synapse       Date:  1991-10       Impact factor: 2.562

2.  The distribution of adenosine A1 receptors and 5'-nucleotidase in the brain of some commonly used experimental animals.

Authors:  J Fastbom; A Pazos; J M Palacios
Journal:  Neuroscience       Date:  1987-09       Impact factor: 3.590

3.  Modulation of hippocampal serotonin (5-HT) release by endogenous adenosine.

Authors:  T J Feuerstein; G Hertting; R Jackisch
Journal:  Eur J Pharmacol       Date:  1985-01-02       Impact factor: 4.432

4.  Adenosine A1-receptors in human brain: characterization and autoradiographic visualization.

Authors:  J Fastbom; A Pazos; A Probst; J M Palacios
Journal:  Neurosci Lett       Date:  1986-04-11       Impact factor: 3.046

Review 5.  Physiological roles for adenosine and ATP in synaptic transmission in the spinal dorsal horn.

Authors:  M W Salter; Y De Koninck; J L Henry
Journal:  Prog Neurobiol       Date:  1993-08       Impact factor: 11.685

6.  The role of histamine in the anterior hypothalamus and its functional interaction with the hippocampus on exploratory behavior in adult male rats.

Authors:  E O Alvarez; A M Banzan
Journal:  Behav Brain Res       Date:  1992-06-08       Impact factor: 3.332

7.  Behavioral effects of A1- and A2-selective adenosine agonists and antagonists: evidence for synergism and antagonism.

Authors:  O Nikodijević; R Sarges; J W Daly; K A Jacobson
Journal:  J Pharmacol Exp Ther       Date:  1991-10       Impact factor: 4.030

8.  Behavioural actions of prolactin locally applied into the hippocampus of adult female rats.

Authors:  E O Alvarez; A M Banzan
Journal:  J Neural Transm Gen Sect       Date:  1994

9.  Adenosine measurement by a rapid HPLC-fluorometric method: induced changes of adenosine content in regions of rat brain.

Authors:  W J Wojcik; N H Neff
Journal:  J Neurochem       Date:  1982-07       Impact factor: 5.372

10.  Modulation of striatal dopaminergic function by local injection of 5'-N-ethylcarboxamide adenosine.

Authors:  R D Green; H K Proudfit; S M Yeung
Journal:  Science       Date:  1982-10-01       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.